Spontaneous tumor regression in a syngeneic rat model of liver cancer: Implications for survival studies

Journal of Vascular and Interventional Radiology

Volumn 23, Issue 12, 2012, Pages 1685-1691

  Buijs, Manon ^a   Geschwind, Jean Francois H ^a   Syed, Labiq H ^a   Ganapathy Kanniappan, Shanmugasundaram ^a   Kunjithapatham, Rani ^a   Wijlemans, Joost W ^a,b   Kook Kwak, Byung ^a,c   Ota, Shinichi ^a   Vali, Mustafa ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c Chung Ang University College of Medicine   (South Korea)

Author keywords

H E; HCC; hematoxylin and eosin; hepatocellular carcinoma; IL; interleukin

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 6;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CANCER TRANSPLANTATION; HEPATOMA CELL; KINETICS; LIVER CANCER; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR REGRESSION; TUMOR VOLUME; ULTRASOUND;

ANIMALS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; HUMANS; LIVER NEOPLASMS; NEOPLASM REGRESSION, SPONTANEOUS; NEOPLASMS, EXPERIMENTAL; RATS; RATS, SPRAGUE-DAWLEY; SURVIVAL ANALYSIS; SURVIVAL RATE; TRANSPLANTATION, ISOGENEIC;

EID: 84870047914     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2012.08.025     Document Type: Article

References (21)

1. R.N. Aravalli, J. Golzarian, and E.N. Cressman Animal models of cancer in interventional radiology Eur Radiol 19 2009 1049 1053
2. P. Newell, A. Villanueva, S.L. Friedman, K. Koike, and J.M. Llovet Experimental models of hepatocellular carcinoma J Hepatol 48 2008 858 879
3. A.B. Novikoff A transplantable rat liver tumor induced by 4-dimethylaminoazobenzene Cancer Res 17 1957 1010 1027
4. S.M. Thompson, M.R. Callstrom, and B. Knudsen Development and preliminary testing of a translational model of hepatocellular carcinoma for MR imaging and interventional oncologic investigations J Vasc Interv Radiol 23 2012 385 395
5. S. Ju, G. McLennan, and S.L. Bennett Technical aspects of imaging and transfemoral arterial treatment of N1-S1 tumors in rats: an appropriate model to test the biology and therapeutic response to transarterial treatments of liver cancers J Vasc Interv Radiol 20 2009 410 414
6. W.Y. Chen, C.J. Chen, J.W. Liao, and F.C. Mao Chromium attenuates hepatic damage in a rat model of chronic cholestasis Life Sci 84 2009 606 614
7. T. Tsujimoto, S. Kuriyama, and M. Yamazaki Augmented hepatocellular carcinoma progression and depressed Kupffer cell activity in rat cirrhotic livers Int J Oncol 18 2001 41 47
8. T.Y. Luo, B.T. Hsieh, and S.J. Wang Preparation and biodistribution of rhenium-188 ECD/Lipiodol in rats following hepatic arterial injection Nucl Med Biol 31 2004 671 677
9. S. Bar-Yehuda, S.M. Stemmer, and L. Madi The A3 adenosine receptor agonist CF102 induces apoptosis of hepatocellular carcinoma via de-regulation of the Wnt and NF-kappaB signal transduction pathways Int J Oncol 33 2008 287 295
10. K.H. Chi, H.E. Wang, and F.D. Chen Preclinical evaluation of locoregional delivery of radiolabeled iododeoxyuridine and thymidylate synthase inhibitor in a hepatoma model J Nucl Med 42 2001 345 351
11. E. Garin, B. Denizot, and J. Roux Description and technical pitfalls of a hepatoma model and of intra-arterial injection of radiolabelled lipiodol in the rat Lab Anim 39 2005 314 320
12. Y. Guo, N. Jin, and R. Klein Gas challenge-blood oxygen level-dependent (GC-BOLD) MRI in the rat Novikoff hepatoma model Magn Reson Imaging 30 2012 133 138
13. Y. Guo, Y. Zhang, and R. Klein Irreversible electroporation therapy in the liver: longitudinal efficacy studies in a rat model of hepatocellular carcinoma Cancer Res 70 2010 1555 1563
14. S. Becker, V. Ardisson, and N. Lepareur Increased Lipiodol uptake in hepatocellular carcinoma possibly due to increased membrane fluidity by dexamethasone and tamoxifen Nucl Med Biol 37 2010 777 784
15. H.P. Morris, C.A. Velat, B.P. Wagner, M. Dahlgard, and F.E. Ray Studies of carcinogenicity in the rate of derivatives of aromatic amines related to N-2-fluorenylacetamide J Natl Cancer Inst 24 1960 149 180
16. A.M. Babsky, S. Ju, S. Bennett, B. George, G. McLennan, and N. Bansal Effect of implantation site and growth of hepatocellular carcinoma on apparent diffusion coefficient of water and sodium MRI NMR Biomed 25 2012 312 321
17. K.H. Lee, E. Liapi, and M. Buijs Percutaneous US-guided implantation of Vx-2 carcinoma into rabbit liver: a comparison with open surgical method J Surg Res 155 2009 94 99
18. M.J. Smyth, G.P. Dunn, and R.D. Schreiber Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity Adv Immunol 90 2006 1 50
19. M.D. Vesely, M.H. Kershaw, R.D. Schreiber, and M.J. Smyth Natural innate and adaptive immunity to cancer Annu Rev Immunol 29 2011 235 271
20. S. Radoja, T.D. Rao, D. Hillman, and A.B. Frey Mice bearing late-stage tumors have normal functional systemic T cell responses in vitro and in vivo J Immunol 164 2000 2619 2628
21. S.I. Grivennikov, F.R. Greten, and M. Karin Immunity, inflammation, and cancer Cell 140 2010 883 899